Jiangsu Aoyang Health Industry Co.ltd. (SHE:002172)

SHE:002172 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	1,858	1,999	2,165	2,008	1,429	1,885
Other Revenue	10.29	10.29	8.48	13.77	-	-
Revenue	1,869	2,010	2,174	2,021	1,429	1,885
Revenue Growth (YoY)	-8.90%	-7.54%	7.54%	41.41%	-24.18%	-36.79%
Cost of Revenue	1,616	1,745	1,885	1,741	989.31	1,453
Gross Profit	252.85	264.64	289.06	280.15	440.06	431.78
Selling, General & Admin	138.63	162.56	189.61	198.57	370.95	295.23
Research & Development	-	-	-	-	-	1.27
Other Operating Expenses	10.56	11.07	11.01	11.52	30.59	17.09
Operating Expenses	160.57	177.14	203.48	164.97	453.88	398.93
Operating Income	92.28	87.49	85.58	115.17	-13.82	32.85
Interest Expense	-29.9	-39.38	-43.19	-62.56	-137.76	-152.16
Interest & Investment Income	4.63	22.5	45.19	19.04	15.85	34.72
Currency Exchange Gain (Loss)	0.01	0.01	0.02	0.07	-0.03	0.01
Other Non Operating Income (Expenses)	-14.93	-13.82	-10.74	-54.46	-16.64	-35.99
EBT Excluding Unusual Items	52.1	56.81	76.87	17.26	-152.4	-120.57
Gain (Loss) on Sale of Investments	-0.85	-1.31	-	-15.89	-3.98	23.84
Gain (Loss) on Sale of Assets	-0.05	-0.06	0.03	-0.01	8.8	111.92
Asset Writedown	-0.14	-0.14	-1	-0.05	-745.14	-50.88
Legal Settlements	-	-	-17.46	-20	-	-8.85
Other Unusual Items	9.88	9.88	11.51	17.72	53.24	29.78
Pretax Income	60.93	65.18	69.94	-0.96	-839.48	-14.76
Income Tax Expense	18.6	23.94	19.68	14.76	-11.43	32.94
Earnings From Continuing Operations	42.33	41.24	50.26	-15.72	-828.05	-47.7
Earnings From Discontinued Operations	-	-	-	-	-239.15	-423.53
Net Income to Company	42.33	41.24	50.26	-15.72	-1,067	-471.22
Minority Interest in Earnings	-0.34	-0.68	-0.58	0.36	28.28	12.23
Net Income	42	40.56	49.68	-15.37	-1,039	-458.99
Net Income to Common	42	40.56	49.68	-15.37	-1,039	-458.99
Net Income Growth	-13.82%	-18.36%	-	-	-	-
Shares Outstanding (Basic)	811	811	828	768	775	778
Shares Outstanding (Diluted)	811	811	828	768	775	778
Shares Change (YoY)	-2.01%	-2.03%	7.78%	-0.91%	-0.34%	0.64%
EPS (Basic)	0.05	0.05	0.06	-0.02	-1.34	-0.59
EPS (Diluted)	0.05	0.05	0.06	-0.02	-1.34	-0.59
EPS Growth	-12.05%	-16.67%	-	-	-	-
Free Cash Flow	209.4	-28.2	-9.29	-226.97	-254.58	-51.9
Free Cash Flow Per Share	0.26	-0.04	-0.01	-0.29	-0.33	-0.07
Gross Margin	13.53%	13.17%	13.30%	13.86%	30.79%	22.91%
Operating Margin	4.94%	4.35%	3.94%	5.70%	-0.97%	1.74%
Profit Margin	2.25%	2.02%	2.29%	-0.76%	-72.68%	-24.35%
Free Cash Flow Margin	11.21%	-1.40%	-0.43%	-11.23%	-17.81%	-2.75%
EBITDA	138.22	141.28	149.83	183.18	199.8	338.71
EBITDA Margin	7.40%	7.03%	6.89%	9.06%	13.98%	17.97%
D&A For EBITDA	45.95	53.79	64.25	68.01	213.63	305.87
EBIT	92.28	87.49	85.58	115.17	-13.82	32.85
EBIT Margin	4.94%	4.35%	3.94%	5.70%	-0.97%	1.74%
Effective Tax Rate	30.52%	36.72%	28.14%	-	-	-
Revenue as Reported	1,869	2,010	2,174	2,021	3,029	3,083
Advertising Expenses	-	2.46	1.91	2	3.27	3.72

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.